Azenta received full repayment of a $35 million secured vendor Loan before maturity, including $35,373,333 with accrued interest. The repayment means Azenta now holds the entire $63,000,000 B Medical Systems purchase price in cash, while the related pledge was released and the transaction’s Credit exposure was retired.
Key Highlights
- Thelema repaid the $35,000,000 principal plus accrued interest, totaling $35,373,333, on September 3, 2026.
- The vendor loan bore interest at 6.0% per annum and was repaid before its three-month maturity.
- Azenta received the entire $63,000,000 purchase price in cash, and the share pledge was released.
Azenta, Inc. (NASDAQ: AZTA) received $35 million in full repayment of a secured vendor loan before maturity.
$35 Million Loan Repaid Early
Azenta Germany GmbH provided Thelema S.à r.l. With a secured term loan carrying an aggregate principal amount of $35,000,000. The Facility bore interest at 6.0% per annum, matured three months after funding, and allowed repayment before Maturity without a penalty. The $35,000,000 vendor loan covered part of the $63,000,000 purchase price at closing. On September 3, 2026, Thelema repaid the outstanding loan and accrued interest in an aggregate amount of $35,373,333. The repayment satisfied and discharged all obligations under the Vendor Loan Agreement, which then terminated, while the share pledge was released.
Full Cash Proceeds Complete Divestiture
The company said the repayment completes the divestiture and retires the credit exposure associated with the transaction. The company linked the outcome to its stated approach to Capital allocation.
FAQs
Q: What did Azenta receive from the B Medical Systems loan repayment?
A: Azenta received $35,373,333 from Thelema, covering the $35,000,000 principal and all accrued interest. The vendor loan was repaid in full before maturity.
Q: What happened to Azenta’s B Medical Systems purchase proceeds?
A: Azenta received the entire $63,000,000 purchase price in cash. The repayment completed the divestiture and retired the transaction’s credit exposure.
Q: What secured Azenta’s vendor loan to Thelema?
A: The $35,000,000 vendor loan was secured by a pledge over 100% of B Medical Systems’ equity interests. The pledge was released after repayment.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.